Search research articles
Contact Us
Filters
Showing results (241-250 of 279) with videos related to
Page
of 28
Sort By:
World Journal of Urology
|
August 15, 2018
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer
Mario I Fernández, Maurizio Brausi, Peter E Clark, et al.
Urology
|
March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results
W R Fair, M S Cookson, N Stroumbakis, et al.
American Journal of Human Genetics
|
March 4, 2014
An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility
Joan P Breyer, Daniel C Dorset, Travis A Clark, et al.
The Journal of Urology
|
September 25, 2012
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience
Samuel D Kaffenberger, Kirk A Keegan, Neil K Bansal, et al.
The Journal of Urology
|
September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II
William T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology
|
September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
William T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 21, 2017
Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression
Ding Xia, Doan V Lai, Weijuan Wu, et al.
The Journal of Urology
|
January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes
Michael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
Plos One
|
May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation
David J DeGraff, Peter E Clark, Justin M Cates, et al.
The Journal of Urology
|
May 19, 2007
Guideline for the management of clinically localized prostate cancer: 2007 update
Ian Thompson, James Brantley Thrasher, Gunnar Aus, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 279) with videos related to
Sort By:
Page
of 28
World Journal of Urology
|
August 15, 2018
Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer
Mario I Fernández, Maurizio Brausi, Peter E Clark, et al.
Urology
|
March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results
W R Fair, M S Cookson, N Stroumbakis, et al.
American Journal of Human Genetics
|
March 4, 2014
An expressed retrogene of the master embryonic stem cell gene POU5F1 is associated with prostate cancer susceptibility
Joan P Breyer, Daniel C Dorset, Travis A Clark, et al.
The Journal of Urology
|
September 25, 2012
Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience
Samuel D Kaffenberger, Kirk A Keegan, Neil K Bansal, et al.
The Journal of Urology
|
September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II
William T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Urology
|
September 22, 2020
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
William T Lowrance, Rodney H Breau, Roger Chou, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
November 21, 2017
Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression
Ding Xia, Doan V Lai, Weijuan Wu, et al.
The Journal of Urology
|
January 16, 2007
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes
Michael S Cookson, Gunnar Aus, Arthur L Burnett, et al.
Plos One
|
May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation
David J DeGraff, Peter E Clark, Justin M Cates, et al.
The Journal of Urology
|
May 19, 2007
Guideline for the management of clinically localized prostate cancer: 2007 update
Ian Thompson, James Brantley Thrasher, Gunnar Aus, et al.
Page
of 28